Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Transgenic Organisms00:53

Transgenic Organisms

Overview
Types of Genetic Transfer Between Organisms02:18

Types of Genetic Transfer Between Organisms

Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status of assisted peritoneal dialysis in Japan: A nationwide questionnaire survey.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Peritoneal dialysis-related infections in elderly patients.

Clinical and experimental nephrology·2024
Same author

Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan.

Clinical and experimental nephrology·2023
Same author

The Transfer of the Hepatocyte Growth Factor Gene by Macrophages Ameliorates the Progression of Peritoneal Fibrosis in Mice.

International journal of molecular sciences·2023
Same author

Comparison of the 2013 and 2019 Nationwide Surveys on the Management of Chronic Kidney Disease by General Practitioners in Japan.

Journal of clinical medicine·2022
Same author

The influence of Japanese general practitioners' familiarity with nephrologists on the management of chronic kidney disease.

Journal of nephrology·2022

Related Experiment Video

Updated: Jul 19, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
11:11

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

Gene transfer using nonviral delivery systems.

Masanobu Miyazaki1, Yoko Obata, Katsushige Abe

  • 1Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan. msnbmiya-ngs@umin.ac.jp

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|October 19, 2006
PubMed
Summary

Gene therapy offers a novel approach to combat peritoneal sclerosis, a major cause of dialysis failure. Nonviral vectors show promise for safely delivering therapeutic genes to the peritoneal membrane, improving treatment outcomes.

More Related Videos

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)

Published on: May 24, 2022

Related Experiment Videos

Last Updated: Jul 19, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
11:11

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)

Published on: May 24, 2022

Area of Science:

  • Biotechnology
  • Nephrology
  • Regenerative Medicine

Background:

  • Peritoneal dialysis failure is often caused by peritoneal membrane dysfunction.
  • Structural changes, including peritoneal sclerosis and increased extracellular matrix, underlie this dysfunction.
  • Current treatments lack specific interventions for peritoneal sclerosis progression.

Purpose of the Study:

  • To review gene transfer strategies using nonviral vectors for treating peritoneal sclerosis.
  • To highlight the potential of gene therapy in preventing peritoneal membrane failure.
  • To discuss the advantages of nonviral vectors over viral vectors in this context.

Main Methods:

  • Review of gene transfer vector systems, focusing on nonviral methods.
  • Discussion of electroporation, liposomes, and cationized gelatin microspheres for peritoneal gene delivery.
  • Analysis of current limitations and future directions in nonviral vector research for peritoneal dialysis.

Main Results:

  • Nonviral vectors offer advantages over viral vectors, including reduced immunogenicity and toxicity.
  • Advancements in delivery methods and gene design enhance the efficiency, specificity, and control of nonviral vectors.
  • Gene therapy using nonviral vectors presents a potential therapeutic strategy for peritoneal sclerosis.

Conclusions:

  • Nonviral gene transfer holds significant potential for treating peritoneal sclerosis and improving peritoneal dialysis outcomes.
  • Further research and development are needed to optimize nonviral vector systems for clinical application.
  • Genetic modification of the peritoneal membrane could revolutionize the management of peritoneal dialysis complications.